Solutions

We have a solution for everything – and the corresponding experience. In our current seven areas of expertise, we are at your disposal with our comprehensive know-how.

All Solutions

Software solutions

Software solutions

With our Werum PAS-X MES - on premise or cloud-based - and our software solutions for analysis, track & trace, networked factories, and intelligent packaging, we are the world's leading supplier and partner to the pharmaceutical and biotech industries.

Overview Software solutions

Handling systems

Handling systems

We are specialists for complete handling systems for pharmaceutical and medical products. Our solutions are decisive in the field of contactless and safe transport of e.g. glass syringes.

Overview Handling systems

Inspection machines

Inspection

As the world's leading inspection expert, we develop solutions for the pharmaceutical and biotech industries. Our range of products extends from high-performance machines and semi-automatic machines to laboratory units and inspection applications for in-process control.

Overview Inspection

Machine finder

Packaging machines

Packaging machines

We are a leading supplier of packaging machines for liquid and solid pharmaceutical and medical products. With our blister, sachet and stick packaging machines we offer solutions for primary packaging. Our side and topload cartoners set standards worldwide for secondary packaging.

Overview Packaging machines

K.Pak Topload Case Packer

Introducing our latest solution from Körber; the K.Pak Topload Case Packer! Created specifically for the pharmaceutical industry, the K.Pak solution provides operator-friendly machines to complete any production line. Our solution focuses on innovative technology, high-quality design and expert handling and packaging of your product. It’s time to start connecting the dots with Körber!

Packaging solutions

Packaging solutions

As long-standing specialists, we develop packaging solutions for innovative and high-quality secondary pharmaceutical packaging made of cardboard. We offer you solutions for counterfeit protection, standard folding boxes and much more.

Overview Packaging solutions

Consulting

Consulting

Our experts will advise you during the analysis of your requirements, show you optimisation potential and support you during the implementation of projects in all areas of the pharmaceutical, biotech and medical device industry.

Overview Consulting

Blog

Digital Pharma – The revolution we are part of

The rapid adoption of new technologies, such as Mobile, Internet of Things (IoT), Advanced Analytics or Cloud, is transforming businesses across industries – and will also impact healthcare significantly!

Over the next decade in healthcare we will see smartphones as hub of a “body area network”, integrating data, analysis, and real-time feedback to patients and caregivers. Another innovation will be sensors that are integrated into medical products and processes, linking patients and healthcare professionals (HCP), feeding insights to product development and marketing.

Technology-related trends

Based on our studies we haveidentified five technology-related trends that will lead to major disruptionsin the pharma and biotech industry by 2025:

  1. New technologies make outcome-based care easier
    Payors and providers intervene beyond the pill and between visits to HCP, leverage technology to drive on outcomes and value.
  2. Patients are more engaged in their health
    Patients increasingly use digital channels to engage in their health and they are savvier about products as well as services.
  3. Non-traditional players move into healthcare tech
    New players will act as intermediaries, aggregating data and building platforms essential to a pharmaco’s business.
  4. More transparency into product performance
    Data on product performance is increasingly generated outside pharma companies, often owned by consumers.
  5. New generation of tech-enablement for core biz processes
    Advanced analytics, sensors and the automation of complex decisions allow a step change in efficiency, speed, quality and responsiveness.

To sum it up: Patient engagement capabilities are core to commercial models, competitors and non-traditional entrants seize control points, and the expectations on efficiency and agility will rise dramatically.

Business opportunities

Based on these technology-related trends we see huge business opportunities within the pharma and biotech industry to drive value from digital:

  1. Sensors and digital services for tailored care 24/7
    Build digital services, apps and platforms delivering beyond-the-pill care as part of a suite of therapy area solutions.
  2. Omni-channel conversations across HCPs and patient decision journeys
    Foster the dialogue between patients, HCPs, and caregivers to develop relationships, provide support and generate insights.
  3. Advanced analytics to gain real-world insights and demonstrate value
    Build analytics and data access capabilities to drive distinctive insights on unmet needs, safety and efficacy as well as personalized therapy.
  4. Automate processes to improve cost, responsiveness, and agility
    Bring safe drugs to market faster, with improved agility and efficiency.

Examples for digital pharma apps

Tailored care 24/7
By 2025 medication will be one element of a therapy that is customized based on many streams of data. How will it work? Body area networks containing sensors monitor and transmit physiological variables in real time to a cloud. If, for example, the glucose level decreases, a safety signal is triggered to the pharma company and recorded in the patient’s electronic health record (EHR). The safety signal is integrated with other wearables and EHR data by cloud analytics. A proactive alert is sent to the physician and the patient to prompt dose adjustment.

Automated processes
We also envision that by 2025 real-time automation is used to increase efficiency and introduce automation across processes. Supply chains will be highly automated with RFID-based tracking of relevant inputs and vendors. This leads to real-time resource planning, tracking and network optimization across manufacturing and distribution. Business support functions rely on automated digital workflows and better decision-support tools. Many in-house business applications are replaced by cloud-based services. In clinical trials, for instance, predictive analytics are widely adopted to optimize site, investigator and patient selection. Enrollment and dossier submission become entirely digital and cloud-based.

Digital transformation

Digital is not only transforming patient care and existing business models – it will also revolutionize pharma operations and supply chains. The most important technologies we have identified are the Internet of Things (IoT) and Industry 4.0. And innovations have already started to impact the entire pharma value chain, from research & development, regulatory & safety to manufacturing, market access and commercialization. Pharma goes digital – and we are all part of it!

Comments

No comments

Write comment

* These fields are required

Back to top
Back to top